References
- FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
- JemalASiegelRWardEHaoYXuJThunMJCancer statistics, 2009CA Cancer J Clin200959422524919474385
- OxnardGRBinderAJannePANew targetable oncogenes in non-small-cell lung cancerJ Clin Oncol20133181097110423401445
- PaoWGirardNNew driver mutations in non-small-cell lung cancerLancet Oncol201112217518021277552
- RosellRBivonaTGKarachaliouNGenetics and biomarkers in personalisation of lung cancer treatmentLancet2013382989372073123972815
- CoxGJonesJLO’ByrneKJMatrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancerClin Cancer Res2000662349235510873086
- HirschFRVarella-GarciaMBunnPAJrEpidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosisJ Clin Oncol200321203798380712953099
- VolmMRittgenWDringsPPrognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomasBr J Cancer19987746636699484827
- LinardouHDahabrehIJBafaloukosDKosmidisPMurraySSomatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLCNat Rev Clin Oncol20096635236619483740
- FukuokaMYanoSGiacconeGMulti-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]J Clin Oncol200321122237224612748244
- KrisMGNataleRBHerbstRSEfficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trialJAMA2003290162149215814570950
- ShepherdFARodrigues PereiraJCiuleanuTErlotinib in previously treated non-small-cell lung cancerN Engl J Med2005353212313216014882
- WakelingAEGuySPWoodburnJRZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapyCancer Res200262205749575412384534
- MoyerJDBarbacciEGIwataKKInduction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinaseCancer Res19975721483848489354447
- LynchTJBellDWSordellaRActivating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinibN Engl J Med2004350212129213915118073
- PaezJGJannePALeeJCEGFR mutations in lung cancer: correlation with clinical response to gefitinib therapyScience200430456761497150015118125
- YunCHMengwasserKETomsAVThe T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATPProc Natl Acad Sci U S A200810562070207518227510
- MitsudomiTSudaKYatabeYSurgery for NSCLC in the era of personalized medicineNat Rev Clin Oncol201310423524423438759
- JannePAGrayNSettlemanJFactors underlying sensitivity of cancers to small-molecule kinase inhibitorsNat Rev Drug Discov20098970972319629074
- PaoWChmieleckiJRational, biologically based treatment of EGFR-mutant non-small-cell lung cancerNat Rev Cancer2010101176077420966921
- SharmaSVBellDWSettlemanJHaberDAEpidermal growth factor receptor mutations in lung cancerNat Rev Cancer20077316918117318210
- WheelerDLDunnEFHarariPMUnderstanding resistance to EGFR inhibitors-impact on future treatment strategiesNat Rev Clin Oncol20107949350720551942
- HolohanCVan SchaeybroeckSLongleyDBJohnstonPGCancer drug resistance: an evolving paradigmNat Rev Cancer2013131071472624060863
- KobayashiSBoggonTJDayaramTEGFR mutation and resistance of non-small-cell lung cancer to gefitinibN Engl J Med2005352878679215728811
- PaoWMillerVAPolitiKAAcquired resistance of lung adeno-carcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domainPLoS Med200523e7315737014
- DossGPRajithBChakrabortyCNagaSundaramNAliSKZhuHStructural signature of the G719S-T790M double mutation in the EGFR kinase domain and its response to inhibitorsSci Rep20144586825091415
- YoshikawaSKukimoto-NiinoMParkerLStructural basis for the altered drug sensitivities of non-small cell lung cancer-associated mutants of human epidermal growth factor receptorOncogene2013321273822349823
- NiederstMJEngelmanJABypass mechanisms of resistance to receptor tyrosine kinase inhibition in lung cancerSci Signal20136294re624065147
- CareyKDGartonAJRomeroMSKinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinibCancer Res200666168163817116912195
- Godin-HeymannNBryantIRiveraMNOncogenic activity of epidermal growth factor receptor kinase mutant alleles is enhanced by the T790M drug resistance mutationCancer Res200767157319732617671201
- MulloyRFerrandAKimYEpidermal growth factor receptor mutants from human lung cancers exhibit enhanced catalytic activity and increased sensitivity to gefitinibCancer Res20076752325233017332364
- KongHJMooneyDJMicroenvironmental regulation of biomacro-molecular therapiesNat Rev Drug Discov20076645546317541418
- McMillinDWNegriJMMitsiadesCSThe role of tumour-stromal interactions in modifying drug response: challenges and opportunitiesNat Rev Drug Discov201312321722823449307
- MaeshimaAMNikiTMaeshimaAYamadaTKondoHMatsunoYModified scar grade: a prognostic indicator in small peripheral lung adenocarcinomaCancer200295122546255412467069
- ShimosatoYSuzukiAHashimotoTPrognostic implications of fibrotic focus (scar) in small peripheral lung cancersAm J Surg Pathol1980443653737425202
- MuellerMMFusenigNEFriends or foes – bipolar effects of the tumour stroma in cancerNat Rev Cancer200441183984915516957
- XieMZhangLHeCSActivation of Notch-1 enhances epithelial-mesenchymal transition in gefitinib-acquired resistant lung cancer cellsJ Cell Biochem201211351501151322173954
- SiricaAEThe role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinomaNat Rev Gastroenterol Hepatol201191445422143274
- MadarSGoldsteinIRotterV‘Cancer associated fibroblasts’ – more than meets the eyeTrends Mol Med201319844745323769623
- ThieryJPSleemanJPComplex networks orchestrate epithelial-mesenchymal transitionsNat Rev Mol Cell Biol20067213114216493418
- GusenbauerSVlaicuPUllrichAHGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitorsOncogene201332333846385623045285
- ByersLADiaoLWangJAn epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistanceClin Cancer Res201319127929023091115
- WangWLiQYamadaTCrosstalk to stromal fibroblasts induces resistance of lung cancer to epidermal growth factor receptor tyrosine kinase inhibitorsClin Cancer Res200915216630663819843665
- FuchsBCFujiiTDorfmanJDEpithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cellsCancer Res20086872391239918381447
- YaoZFenoglioSGaoDCTGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancerProc Natl Acad Sci U S A201010735155351554020713723
- ChungJHRhoJKXuXClinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIsLung Cancer201173217618221168239
- SequistLVWaltmanBADias-SantagataDGenotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitorsSci Transl Med201137575ra26
- UramotoHShimokawaHHanagiriTKuwanoMOnoMExpression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinomaLung Cancer201173336136521315472
- AnJEnomotoAWengLSignificance of cancer-associated fibroblasts in the regulation of gene expression in the leading cells of invasive lung cancerJ Cancer Res Clin Oncol201313937938823108890
- NavabRStrumpfDBandarchiBPrognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancerProc Nati Acad Sci U S A20111081771607165
- WaldOIzharUAmirGInteraction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: role in non-small cell lung cancer tumor proliferationJ Thorac Cardiovasc Surg201114161503151221463876
- VicentSSaylesLCVakaDCross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivoCancer Res201272225744575622962265
- ChoeCShinYSKimSHTumor-stromal interactions with direct cell contacts enhance motility of non-small cell lung cancer cells through the hedgehog signaling pathwayAnticancer Res20133393715372324023301
- KimSHChoeCShinYSHuman lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in co-cultureAnticancer Res20133352001200923645749
- SohJOkumuraNLockwoodWWOncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cellsPLoS One2009410e746419826477
- AyersKLTherondPPEvaluating smoothened as a G-protein-coupled receptor for hedgehog signallingTrends Cell Biol201020528729820207148
- AhmadAMaitahMYGinnebaughKRInhibition of hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAsJ Hematol Oncol2013617724199791
- IsohataNAoyagiKMabuchiTHedgehog and epithelial-mesenchymal transition signaling in normal and malignant epithelial cells of the esophagusInt J Cancer200912551212122119431210
- JoostSAlmadaLLRohnalterVGLI1 inhibition promotes epithelial-to-mesenchymal transition in pancreatic cancer cellsCancer Res2012721889922086851
- MaitahMYAliSAhmadAGadgeelSSarkarFHUp-regulation of sonic hedgehog contributes to TGF-beta1-induced epithelial to mesenchymal transition in NSCLC cellsPLoS One201161e1606821249152
- OhtaHAoyagiKFukayaMCross talk between hedgehog and epithelial-mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancersBr J Cancer2009100238939819107131
- OmenettiAPorrelloAJungYHedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humansJ Clin Invest2008118103331334218802480
- YooYAKangMHLeeHJSonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancerCancer Res201171227061707021975935
- ZhengXVittarNBGaiXThe transcription factor GLI1 mediates TGFbeta1 driven EMT in hepatocellular carcinoma via a SNAI1-dependent mechanismPLoS One2012711e4958123185371
- WongGSRustgiAKMatricellular proteins: priming the tumour microenvironment for cancer development and metastasisBr J Cancer2013108475576123322204
- ChenJKTaipaleJCooperMKBeachyPAInhibition of hedgehog signaling by direct binding of cyclopamine to smoothenedGenes Dev200216212743274812414725
- TaipaleJChenJKCooperMKEffects of oncogenic mutations in smoothened and patched can be reversed by cyclopamineNature200040667991005100910984056
- BijlsmaMFBorensztajnKSRoelinkHPeppelenboschMPSpekCASonic hedgehog induces transcription-independent cytoskeletal rearrangement and migration regulated by arachidonate metabolitesCell Signal200719122596260417884337
- PolizioAHChinchillaPChenXKimSManningDRRioboNAHeterotrimeric Gi proteins link hedgehog signaling to activation of Rho small GTPases to promote fibroblast migrationJ Biol Chem201128622195891959621474452
- SasakiNKurisuJKengakuMSonic hedgehog signaling regulates actin cytoskeleton via Tiam1-Rac1 cascade during spine formationMol Cell Neurosci201045433534420654717
- ZakowskiMFLadanyiMKrisMGMemorial Sloan-Kettering Cancer Center Lung Cancer OncoGenome GroupEGFR mutations in small-cell lung cancers in patients who have never smokedN Engl J Med2006355221321516837691
- RobertGGaggioliCBailetOSPARC represses E-cadherin and induces mesenchymal transition during melanoma developmentCancer Res200666157516752316885349
- ZhangZLeeJCLinLActivation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancerNat Genet201244885286022751098
- HuangSHolzelMKnijnenburgTMED12 controls the response to multiple cancer drugs through regulation of TGF-beta receptor signalingCell2012151593795023178117
- AmakyeDJaganiZDorschMUnraveling the therapeutic potential of the hedgehog pathway in cancerNat Med201319111410142224202394
- CufiSBonaviaRVazquez-MartinASilibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivoSci Rep20133245923963283
- JanjiBVallarLAl TanouryZThe actin filament cross-linker L-plastin confers resistance to TNF-alpha in MCF-7 breast cancer cells in a phosphorylation-dependent mannerJ Cell Mol Med2010146A1264127519799649